For example, treatment with tumor necrosis factor alpha (TNF-α) neutralizing drugs (Infliximab and Etanercept) had no beneficial effects on heart failure hospitalization or mortality, and treatment with high doses of Infliximab even caused adverse clinical outcomes [2,3]. Here, TNF is linked to heart failure.